13F-HR: General Electric Co Discloses $1.26 Billion in Holdings as of September 30, 2024

General Electric Co's latest 13F filing reveals significant holdings in GE Healthcare Technologies and Hyliion Holdings Corp as of September 30, 2024.

Summary

• General Electric Co filed its Form 13F for the quarter ended September 30, 2024.
• The filing discloses holdings valued at $1,260,090,193.
• The portfolio includes 13,281,302 shares of GE Healthcare Technologies I Common Stock, valued at $1,246,450,193.
• It also includes 5,500,000 shares of Hyliion Holdings Corp Common Stock, valued at $13,640,000.
• The holdings are managed solely by General Electric Co.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The large holding in GE Healthcare suggests a positive outlook on that specific investment.

Positives

• The filing provides transparency into General Electric Co's investment portfolio.
• The significant investment in GE Healthcare Technologies I Common Stock indicates confidence in the company.

Industry Context

Form 13F filings are a standard requirement for institutional investment managers, providing insights into their investment strategies and portfolio composition. The holdings in GE Healthcare Technologies and Hyliion Holdings reflect GE's investment decisions within the healthcare and electric vehicle sectors.

Comparison to Industry Standards

• Comparing GE's holdings to other large institutional investors would require analyzing their respective 13F filings.
• Benchmarking against industry peers would involve examining similar investment strategies and sector allocations.
• For example, comparing the Hyliion investment to other investments in the EV sector by similar firms would provide context.

Stakeholder Impact

• Shareholders can gain insights into GE's investment strategy.
• The holdings in GE Healthcare Technologies and Hyliion Holdings may influence the market perception of these companies.

Key Dates